× General discussion on topics relevant to child neurology education & practice

UK Government Drug safety update for Chloral Hydrate (6 October 2021)

  • ICNA
  • ICNA's Avatar Topic Author
  • Offline
  • Administrator
  • Administrator
  • Posts: 50
  • Thank you received: 1

The paediatric indication for chloral hydrate (for children aged 2 years and older) and cloral (previously chloral) betaine (children aged 12 years and older) has been restricted to short-term treatment (maximum 2 weeks) of severe insomnia only when the child or adolescent has a suspected or definite neurodevelopmental disorder and when the insomnia is interfering with normal daily life. Chloral hydrate and cloral betaine should only be used when other therapies (behavioural and pharmacological) have failed.
2 years 2 weeks ago #1

Please Log in or Create an account to join the conversation.

  • Not Allowed: to create new topic.
  • Not Allowed: to reply.
  • Not Allowed: to edit your message.

Please note that only the topics you have access to are displayed.
You are not logged in